A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.
暂无分享,去创建一个
J. Blohmer | W. Lichtenegger | J. Sehouli | O. Camara | D. Stengel | P. Klare | D. Elling | G. Heinrich | P. Ledwon | G. Oskay | H. Hindenburg